December 28, 2014 8:25 PM ET

Biotechnology

Company Overview of Atreus Pharmaceuticals Corporation

Company Overview

Atreus Pharmaceuticals Corporation is a development-stage biopharmaceutical company in Canada. The company develops in-vivo radiopharmaceutical products suitable for nuclear medicine imaging that will aid in the early diagnosis and management of diseases. It offers Annexin V, a naturally occurring 36kD protein normally found in high levels in the cytoplasm of various cells, including placenta, lymphocytes, monocytes, and biliary and renal tubular epithelium; and a lyophilized diagnostic kit for the preparation of Technetium-99m (Tc-99m) labeled V-128 Annexin, a form of Annexin with a peptide tail that avidly binds the imaging isotope. The company’s Tc-99m labelled Annexin is used in imaging ...

9 Hansen Avenue

Ottawa, ON K2K-2L9

Canada

Founded in 2007

Phone:

613-852-3217

Fax:

613-212-8990

Key Executives for Atreus Pharmaceuticals Corporation

Chief Executive officer
Age: 58
Nuclear Medicine Advisor
Nuclear Medicine Advisor
Nuclear Medicine Advisor
Nuclear Medicine Advisor
Age: 63
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
AlgaeCan Biotech Ltd. Americas
Emerillon Therapeutics Inc. Americas
DNA Labeling Americas
Neuropsychiatrie, Découverte & Innovation Inc. Americas
REPLICor Inc. Americas

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Atreus Pharmaceuticals Corporation, please visit www.atreuspharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.